GeneWeave Biosciences, Inc.
GeneWeave Biosciences, Inc., is a medical diagnostics company focused on infectious diseases. GeneWeave was acquired by Roche Holding AG in 2015.
Acuamark Diagnostics, Inc.
Acuamark Diagnostics is developing novel diagnostic tests to enable low-cost and accurate early detection of colorectal cancer directly from the blood, by isolating and identifying multiple cancer markers. Thus, allowing for improved sensitivity, specificity, and scalability.
